$heff's $tation of $tocks & $olid DD

[pmony5]

TTNP some DD 100 mill $$$ Mkt Cap & as per partner CC ended year with approx 22 million in cash plus now that priority review granted upon approval gets another 50 Million Dollars plus some $1.25 warrants will be exercised in 2013 adding another 14 million in cash. So no dilution worries anymore. Also with Priority review the approval rate doubles to 75% chance of approval versus 38% on Standard review

http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM293684.pdf

2012 Priority review approvals = 77%

Just got great terms & numbers on partner deal

http://finance.yahoo.com/news/titan-pharmaceuticals-licenses-exclusive-probuphine-120000246.html

Also keep in mind buprenorphine hydrochloride has been approved & used for last 10 years in pill form & now sub-lingual but compliance is still very low. TTNP with an implantable 6 month dosage will have triple digit improvement in compliance & should easily become the gold standard in opioid treatment. TTNP will be entering a double digit yearly growth drug arena currently doing over 1.3 Billion a year in sales & fairly conservative & safe to say TTNP should garner 300 to 500 million in peak sales.All for 100 Million dollar market cap ??? will have 85 million in cash upon approval.